Loading…
Chemed Corporation is projected to rise to $742.83 by 2027, a +39% move from its current price of $534.79. CHE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $527.54 | $534.76 | $542.07 | -0.01% |
| Aug 2 | $524.54 | $534.72 | $545.10 | -0.01% |
| Aug 3 | $522.25 | $534.69 | $547.43 | -0.02% |
| Aug 4 | $520.32 | $534.66 | $549.39 | -0.02% |
| Aug 5 | $518.62 | $534.63 | $551.12 | -0.03% |
| Aug 6 | $517.09 | $534.59 | $552.69 | -0.04% |
| Aug 7 | $515.68 | $534.56 | $554.13 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $515.68 | $534.56 | $554.13 | -0.04% |
| Week 2 | $507.84 | $534.33 | $562.20 | -0.09% |
| Week 3 | $501.85 | $534.10 | $568.42 | -0.13% |
| Week 4 | $496.82 | $533.87 | $573.68 | -0.17% |
| Week 5 | $492.41 | $533.64 | $578.32 | -0.22% |
| Week 6 | $488.43 | $533.41 | $582.52 | -0.26% |
| Week 7 | $484.79 | $533.18 | $586.39 | -0.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Chemed Corporation operates in the healthcare sector, providing hospice and palliative care to patients in the United States through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers.
The company runs two segments, VITAS and Roto-Rooter, and also offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Chemed was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed Corporation (CHE) is a healthcare company with a current price of $517.63 per share and a market capitalization of $6.87B, ranking 1105.
The price outlook in the near term shows the 2026 average price at $517.63, with potential up to $671.40 in that year. This suggests a flat-to-upside dynamic around the current level in the short run.
From 2027 onward, the forecast envisions a bullish path, with the 2027 average price at $692.43 and the 2028 average at $898.29, rising through 2029 ($968.66) and 2030 ($1,090.55), and continuing to 2050 with an average price of $6,258.29 and a max of $10,229.95. The implied return profile grows from 0 in 2026 to 1109 in 2050, with sentiment labeled bullish in the later years.
The forecast also shows substantial upside across years, including 2030 min $852.38 and max $1,485.38, 2040 min $2,148.09 and max $4,610.47, and 2050 min $4,145.19 and max $10,229.95, reinforcing a strong growth trajectory over the horizon.
A major floor 31.1% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 13.5% above — clearing it would confirm fresh momentum.
Key CHE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CHE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $522.45 | Buy | $525.09 | Buy |
| MA 10 | $514.66 | Buy | $515.81 | Buy |
| MA 20 | $501.96 | Buy | $501.56 | Buy |
| MA 50 | $464.52 | Buy | $472.98 | Buy |
| MA 100 | $431.53 | Buy | $453.38 | Buy |
| MA 200 | $435.40 | Buy | $451.17 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.12 | Sell |
| Stoch RSI (14) | 65.21 | Neutral |
| CCI (20) | 172.37 | Buy |
| Williams %R (14) | -9.63 | Info |
| MACD (12,26,9) | 1.68 | Buy |
| ROC (12) | 8.72 | Buy |
| Bollinger %B (20,2) | 1.02 | Sell |
| Stochastic %K (14) | 90.37 | Sell |
| TRIX (15) | 0.53 | Buy |
| Awesome (5,34) | 44.23 | Buy |
| Ultimate (7,14,28) | 81.43 | Sell |
| Momentum (10) | 33.28 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 533.43 | Buy |
| ADX (14) | 39.62 | Buy |
| ATR (14) | 6.37 | Info |
The near-term technical picture is bullish.
RSI14 is 70, signaling positive momentum. The 50-day simple moving average is $456.98, and the 200-day simple moving average is $433.55, providing a constructive trend backdrop.
Key support is at $419.31 and resistance at $513.68, with the current 30-day price range spanning $479.60 to $558.68, outlining a band that traders will watch for short-term swings.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $368.59 | $534.79 | $701.92 | 0% | Neutral | |
| $609.07 | $742.83 | $946.69 | +39% | Bullish | |
| $787.53 | $978.77 | $1,281.66 | +83% | Bullish | |
| $850.31 | $1,073.24 | $1,435.60 | +101% | Bullish | |
| $956.86 | $1,224.14 | $1,667.17 | +129% | Bullish | |
| $1,091.23 | $1,413.18 | $1,955.24 | +164% | Bullish | |
| $1,147.60 | $1,503.03 | $2,109.31 | +181% | Bullish | |
| $1,324.63 | $1,753.22 | $2,492.41 | +228% | Bullish | |
| $1,604.67 | $2,145.05 | $3,086.04 | +301% | Bullish | |
| $1,831.44 | $2,471.42 | $3,595.30 | +362% | Bullish | |
| $2,685.69 | $3,780.30 | $5,763.82 | +607% | Bullish | |
| $5,312.52 | $8,020.41 | $13,109.92 | +14.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $368.59 | $534.79 | $623.09 | +0.00% |
| August 2026 | $462.89 | $539.74 | $641.38 | +0.93% |
| September 2026 | $453.47 | $531.79 | $637.87 | -1.47% |
| October 2026 | $460.52 | $542.53 | $655.59 | +2.02% |
| November 2026 | $478.20 | $565.48 | $687.44 | +4.23% |
| December 2026 | $483.96 | $574.26 | $701.92 | +1.55% |
Click any year to see its month-by-month CHE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Chemed Corporation's 2026 outlook centres on $534.79, within a $368.59 to $701.92 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CHE could reach as high as $946.69, with a base case around $742.83 and support toward $609.07 — roughly +39% from $534.79. Momentum favours further upside here.
Expect CHE to range from $787.53 to $1,281.66 through 2028. The $978.77 average target implies a +83% move from current prices. That is up +32% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CHE price prediction for 2029 points to an average of $1,073.24 (low $850.31, high $1,435.60) — a potential gain of +101% on today's $534.79. Momentum favours further upside here.
In 2030, CHE is projected to trade between $956.86 and $1,667.17, averaging $1,224.14 — a potential gain of +129% from today's $534.79. That is up +14% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Chemed Corporation's 2031 outlook centres on $1,413.18, within a $1,091.23 to $1,955.24 range. That is up +15% on the projected 2030 average. That marks a +164% change versus current levels. Momentum favours further upside here.
By 2032, CHE could reach as high as $2,109.31, with a base case around $1,503.03 and support toward $1,147.60 — roughly +181% from $534.79. Buyers look set to stay in control over this stretch.
Expect CHE to range from $1,324.63 to $2,492.41 through 2033. The $1,753.22 average target implies a +228% move from current prices. That is up +17% on the projected 2032 average. Momentum favours further upside here.
The CHE price prediction for 2034 points to an average of $2,145.05 (low $1,604.67, high $3,086.04) — a potential gain of +301% on today's $534.79. Buyers look set to stay in control over this stretch.
In 2035, CHE is projected to trade between $1,831.44 and $3,595.30, averaging $2,471.42 — a potential gain of +362% from today's $534.79. That is up +15% on the projected 2034 average. Momentum favours further upside here.
Chemed Corporation's 2040 outlook centres on $3,780.30, within a $2,685.69 to $5,763.82 range. That is up +53% on the projected 2035 average. That marks a +607% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CHE could reach as high as $13,109.92, with a base case around $8,020.41 and support toward $5,312.52 — roughly +14.0x from $534.79. Momentum favours further upside here.
Investing $1,000 in CHE today (≈ 1.869893 CHE) could be worth
$14,997.3
+$13,997.3 (+1400%) by 2050 · US Dollar
Based on the average projected CHE price of $8,020.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CHEwould be worth at today's price.
$1,000 invested in CHE on Jul 30, 2025 (≈ 2.400557 CHE) would be worth
$1,283.79
+$283.79 (+28.4%) today · 1.28× · US Dollar
Based on a CHE entry price of $416.57 vs. today's $534.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $503.01 | $1,063.18 | +6.3% |
| 1 month ago | $465.74 | $1,148.26 | +14.8% |
| 3 months ago | $422.16 | $1,266.79 | +26.7% |
| 6 months ago | $427.14 | $1,252.03 | +25.2% |
| 1 year ago | $416.57 | $1,283.79 | +28.4% |
| All time (5.0y) ago | $476.07 | $1,123.34 | +12.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CHE forecast.
Our base-case forecast reaches $1,100.00 around 2030.
Implied market cap at $1,100.00: $14.6B
The multi-year forecast indicates a bullish path beyond the near term. By 2030, the average forecast price is $1,090.55 with a min of $852.38 and a max of $1,485.38, and the forecasted ROI is 110.7 with bullish sentiment.
In 2040, the average forecast rises to $3,023.71 with a min of $2,148.09 and a max of $4,610.47, and the forecasted ROI expands to 484.1 under bullish sentiment.
By 2050, the average forecast reaches $6,258.29 with a min of $4,145.19 and a max of $10,229.95, and the forecasted ROI climbs to 1109 with bullish sentiment.
These figures are estimates and not guarantees. They suggest meaningful upside if the trajectory remains supportive, but investors should recognize the uncertainty inherent in long-horizon projections and consider them as scenarios rather than certainties.
Tap a question to reveal the answer.
The 2030 forecast lists min $852.38, avg $1,090.55, max $1,485.38, with ROI 110.7 and bullish sentiment.
Yes. The forecast shows neutral in 2026, then bullish sentiment from 2027 onward, with rising averages and positive ROI through 2050.
Yes. The 2030 forecast has an average price of $1,090.55, with a min of $852.38 and a max of $1,485.38.
Current price is $517.63 and market cap is $6.87B.
The 30-day range is $479.60 to $558.68. RSI14 is 70. SMA50 is $456.98 and SMA200 is $433.55. Support is $419.31 and resistance is $513.68.
Chemed Corporation Community Discussion
0Share your Chemed Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.